Insider Selling: Intuitive Surgical, Inc. (NASDAQ:ISRG) EVP Sells 1,012 Shares of Stock

Intuitive Surgical, Inc. (NASDAQ:ISRG) EVP Robert Desantis sold 1,012 shares of the business’s stock in a transaction dated Friday, October 25th. The stock was sold at an average price of $514.00, for a total transaction of $520,168.00. Following the sale, the executive vice president now directly owns 5,506 shares in the company, valued at $2,830,084. The trade was a 0.00 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this link.

Robert Desantis also recently made the following trade(s):

• On Tuesday, October 29th, Robert Desantis sold 188 shares of Intuitive Surgical stock. The stock was sold at an average price of $506.52, for a total value of $95,225.76.
• On Tuesday, September 10th, Robert Desantis sold 238 shares of Intuitive Surgical stock. The shares were sold at an average price of $477.50, for a total value of $113,645.00.
• On Thursday, August 29th, Robert Desantis sold 188 shares of Intuitive Surgical stock. The stock was sold at an average price of $482.21, for a total value of $90,655.48.
• On Monday, August 26th, Robert Desantis sold 396 shares of Intuitive Surgical stock. The stock was sold at an average price of $486.88, for a total value of $192,804.48.
• On Monday, August 12th, Robert Desantis sold 240 shares of Intuitive Surgical stock. The shares were sold at an average price of $464.76, for a total transaction of $111,542.40.

Intuitive Surgical Trading Down 1.9 %

Intuitive Surgical stock opened at $503.84 on Friday. The firm has a market capitalization of $179.46 billion, a price-to-earnings ratio of 81.00, a P/E/G ratio of 5.11 and a beta of 1.39. Intuitive Surgical, Inc. has a 12-month low of $260.17 and a 12-month high of $523.34. The firm has a 50 day moving average of $490.01 and a 200 day moving average of $445.70.

Institutional Inflows and Outflows

Hedge funds have recently bought and sold shares of the company. Summit Global Investments bought a new position in Intuitive Surgical in the 3rd quarter worth approximately $306,000. TFB Advisors LLC increased its holdings in shares of Intuitive Surgical by 4.8% in the third quarter. TFB Advisors LLC now owns 1,718 shares of the medical equipment provider’s stock worth $844,000 after purchasing an additional 79 shares during the last quarter. Portside Wealth Group LLC lifted its position in shares of Intuitive Surgical by 15.5% in the third quarter. Portside Wealth Group LLC now owns 1,165 shares of the medical equipment provider’s stock worth $572,000 after buying an additional 156 shares in the last quarter. Consolidated Planning Corp boosted its stake in Intuitive Surgical by 17.4% during the third quarter. Consolidated Planning Corp now owns 8,099 shares of the medical equipment provider’s stock valued at $3,979,000 after buying an additional 1,198 shares during the last quarter. Finally, Valley Brook Capital Group Inc. purchased a new position in Intuitive Surgical during the 3rd quarter valued at approximately $236,000. Institutional investors own 83.64% of the company’s stock.

Wall Street Analysts Forecast Growth

Several brokerages recently weighed in on ISRG. Redburn Atlantic raised shares of Intuitive Surgical from a “neutral” rating to a “buy” rating and raised their price target for the company from $380.00 to $510.00 in a research report on Friday, August 2nd. Truist Financial boosted their price target on Intuitive Surgical from $520.00 to $570.00 and gave the stock a “buy” rating in a research note on Monday, October 14th. Oppenheimer reaffirmed a “market perform” rating on shares of Intuitive Surgical in a research report on Friday, October 18th. Raymond James boosted their target price on Intuitive Surgical from $500.00 to $540.00 and gave the stock an “outperform” rating in a research report on Monday, October 14th. Finally, Stifel Nicolaus raised their price target on shares of Intuitive Surgical from $475.00 to $525.00 and gave the company a “buy” rating in a report on Friday, October 18th. One analyst has rated the stock with a sell rating, five have assigned a hold rating and fourteen have assigned a buy rating to the company’s stock. According to data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and a consensus price target of $513.74.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.